Class 4 Medicines Defect Information: Galderma (U.K.) Limited, Etrivex 500 micrograms/g Shampoo, EL (22)A/51
Galderma (U.K.) Limited has informed the MHRA that the patient information leaflet (PIL) packaged in specific batches of Etrivex Shampoo is missing safety information
MDR number
MDR 108-11/22
Company name
Galderma (U.K.) Limited
Product name
Etrivex 500 micrograms/g Shampoo, PL 10590/0052
SNOMED Code
11771611000001109
| Batch number | Expiry date | Pack size | First distributed |
|---|---|---|---|
| 0114252 | 07/2023 | 1 x 125ml | 01/10/2020 |
| 0114277 | 07/2023 | 1 x 125ml | 23/12/2020 |
| 0114291 | 04/2023 | 1 x 125ml | 19/03/2021 |
Active Pharmaceutical Ingredient: Clobetasol propionate
Brief description of the problem
Galderma (U.K.) Limited has informed the MHRA that the patient information leaflet (PIL) packaged in specific batches of Etrivex Shampoo is missing the following safety information (in bold):
Section 2: What you need to know before you use Etrivex 500 micrograms/g shampoo
Warnings and precautions
Take special care with Etrivex 500 micrograms/g Shampoo
- When using Etrivex shampoo, it must only be used on the scalp, do not use it as a regular shampoo or on other areas of the body and do not use Etrivex shampoo as a shower gel, body wash or bath foam.
- When treating the scalp with Etrivex shampoo you must not cover the area being treated, for example: a shower cap must not be used as it may make the active substance pass through the skin and affect the other parts of the body.
- When using Etrivex shampoo, avoid contact with the face, eyelids, axillae (armpits), erosive skin (chapped skin) surface and genital regions. Rinse off immediately with water if any product runs from the scalp.
- If you get Etrivex shampoo in your eye(s), wash the affected eye thoroughly with water. If any irritation persists, please seek advice from your doctor.
- If you do not notice an improvement of your scalp psoriasis, please see your doctor.
- Contact your doctor if you experience blurred vision or other visual disturbances.
Section 4: Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Etrivex shampoo may cause the following side effects
Not known (frequency cannot be estimated from the available data)
- Blurred vision
Advice for healthcare professionals
There is no risk to product quality as a result of this issue, therefore the affected batches are not being recalled. Healthcare professionals are advised to exercise caution when dispensing specific batches of the product. Where possible, provide an updated copy of the PIL to the patient and remind the patient to read the leaflet in its entirety before using the medicine. This is available via the link below:
Etrivex 500 micrograms/g Shampoo - Patient Information Leaflet (PIL)
Galderma (U.K.) Limited has confirmed that all future batches will contain the correct PIL. Upon request, Galderma (U.K.) Limited will post hard copies of the updated PIL to wholesalers and pharmacies so that any remaining stock in the dispensary can be supplemented with the correct PIL information.
Advice for patients
Patients should be aware that the Patient Information Leaflet (PIL) in the above batches of Etrivex 500 micrograms/g Shampoo does not contain the most up-to-date safety information on side effects.
If you experience blurred vision and visual disturbances, you should contact your doctor immediately. Any suspected adverse reactions should also be reported via the MHRA Yellow Card scheme.
Further Information
For more information, medical information queries or replacement PIL enquiries, please contact: [email protected]
For stock control queries, please contact: [email protected]
Recipients of this Medicines Notification should bring it to the attention of relevant contacts by copy of this notice. NHS regional teams are asked to forward this to community pharmacists and dispensing general practitioners for information.
Yours faithfully
Defective Medicines Report Centre
10 South Colonnade
Canary Wharf
London
E14 4PU
Telephone +44 (0)20 3080 6574
Download Document